In English | En español
Questions About Cancer? 1-800-4-CANCER

NCI Drug Dictionary

  

allogeneic melanoma vaccine AGI-101H 
A cancer vaccine derived from two gentically modified human melanoma cell lines with potential antineoplastic activity. Allogeneic melanoma vaccine AGI-101H consists of a 1:1 mixture of cells from two genetically modified human melanoma cell lines, designated as Mich1H6 and Mich2H6, that have been gamma-irradiated to render the cells non-proliferative. Upon administration, this vaccine may stimulate a cytotoxic immune response against melanoma tumor cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Code name:AGI-101H